Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Operating Officer
-
Issuer Symbol
-
TARS on Nasdaq
Seshadri Neervannan - trading volume in the past year for Tarsus Pharmaceuticals, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
79,183 |
$5,923,680 |
$74.81 |
16 Dec 2025 |
Direct |
|
|
| Stock Option (right to buy) |
30,628 |
$336,602 |
$10.99 |
05 Mar 2025 |
Direct |
Common Stock |
|
| Restricted Stock Units |
24,060 |
$310,133 |
$12.89 |
15 Mar 2025 |
Direct |
Common Stock |
|
| Common Stock |
475 |
$35,534 |
$74.81 |
16 Dec 2025 |
By daughter |
|
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.